Overview
Cilcare is a French-US based biotechnology company specializing in auditory sciences, dedicated to developing cutting-edge solutions for the characterization, diagnosis, and treatment of hearing disorders and related diseases. Since its inception in 2014, Cilcare has been tackling global hearing health challenges by combining an advanced R&D platform, a promising pipeline of drug candidates, and the power of AI to better characterize different forms of hearing loss, ultimately aiming to revolutionize the medicine of tomorrow.
Company News
Cilcare establishes its Japan subsidiary as its springboard for Asia-Pacific growth
Oct 04, 2026
Posted by Cilcare
